|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-1-13
|
|
pubmed:abstractText |
A prospective randomized phase III clinical trial was conducted to assess whether the addition of tamoxifen (TAM) to the three-agent regimen of cisplatin (CDDP), dacarbazine (DTIC), and carmustine (BCNU) significantly increased the progression-free survival and overall survival of patients with advanced malignant melanoma.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1884-90
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10561229-Adult,
pubmed-meshheading:10561229-Aged,
pubmed-meshheading:10561229-Aged, 80 and over,
pubmed-meshheading:10561229-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10561229-Carmustine,
pubmed-meshheading:10561229-Cisplatin,
pubmed-meshheading:10561229-Dacarbazine,
pubmed-meshheading:10561229-Disease-Free Survival,
pubmed-meshheading:10561229-Eye Neoplasms,
pubmed-meshheading:10561229-Female,
pubmed-meshheading:10561229-Humans,
pubmed-meshheading:10561229-Male,
pubmed-meshheading:10561229-Melanoma,
pubmed-meshheading:10561229-Middle Aged,
pubmed-meshheading:10561229-Prospective Studies,
pubmed-meshheading:10561229-Skin Neoplasms,
pubmed-meshheading:10561229-Survival Rate,
pubmed-meshheading:10561229-Tamoxifen,
pubmed-meshheading:10561229-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
|
|
pubmed:affiliation |
Mayo Clinic and Mayo Foundation, Rochester, and Duluth Community Clinical Oncology Program, Duluth, MN 55905, USA. creagan.edward@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
